The Business of Personalized Medicine Summit

09 September 2014 San Francisco, CA Past Event

Location

South San Francisco Conference Center
San Francisco, CA

Contact Information

Meghan Burton
mburton@foley.com

Agenda

September 9, 2014
The Business of Personalized Medicine Summit features a full-day’s agenda focused on the business opportunities and challenges associated with the advancement of personalized medicine.

Co-hosted by the Personalized Medicine Coalition and Foley & Lardner LLP, the Summit provides an opportunity for biotechnology and pharmaceutical executives as well as healthcare industry stakeholders to engage in fresh discussion regarding business, legal, and regulatory issues that will impact and drive business growth, research and development, and performance in the forthcoming era of personalized medicine. With a strong emphasis on what personalized medicine means to the future of health care economics, and the evolution of disruptive technologies, the Summit will provide attendees with fresh perspective from a wide-array of industry thought leaders.

Featured Topics

  • Finance and Venture Capital: How investment is driving business growth and technology development
  • LDT/CLIA Tests vs Kit Based Test: Investors and Innovators Weigh-In
  • Reimbursement: integrating payor requirements into product development
  • Disruptive Innovation: The business of regenerative medicine, gene therapy and immunotherapy
  • Drug Discovery and Clinical Development: A global perspective on R&D strategies related to personalized medicine
  • Big Data Making an Impact in Healthcare: Generating quality data and converting it to clinical use

Who Should Attend

  • Business, legal and health care professionals interested in industry leaders’ real-world experience on the current state of personalized medicine and where growth and opportunity exist
  • Business, legal and health care professionals interested in discussions regarding the regulatory framework for diagnostics and targeted therapies
  • Executives and entrepreneurs interested in hearing diverse perspectives on both the development and delivery of personalized medicine therapies
  • Payors interested in current status and future possibilities regarding reimbursement of personalized medicine technologies
  • Corporate Counsel in life sciences and health care provider organizations
  • Health care professionals working in the field of personalized medicine
  • Health care and life sciences investors
  • Researchers and academic personnel
  • Not-For-Profit organizations

For more information or to register, visit the 2014 Business of Personalized Medicine Summit's website.

For further information please contact Meghan Burton at mburton@foley.com.

Insights

Do You Know What IMMEX Stands For?
16 July 2019
Dashboard Insights
Does The U.S. Need STRONGER Patents?
16 July 2019
PTAB Trial Insights
California Establishes Fund to Combat Wildfire Threats
15 July 2019
Renewable Energy Outlook
There’s No Place Like Home – But Is That a Reasonable Accommodation?
15 July 2019
Labor & Employment Law Perspectives
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
2019 NDI Executive Exchange
14-15 November 2019
Chicago, IL
MAGI’s Clinical Research Conference
29 October 2019
Las Vegas, NV
Association for Corporate Counsel Annual Meeting 2019
27-30 October 2019
Phoenix, AZ

The Business of Personalized Medicine Summit

Location

South San Francisco Conference Center
San Francisco, CA

Contact Information

Meghan Burton
mburton@foley.com

Agenda

September 9, 2014